SageView Advisory Group
RDY icon

SageView Advisory Group’s Dr. Reddy's Laboratories RDY Stock Holding History

SageView Advisory Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-543
Closed -$7.62K – 2002
2025
Q4 		$7.62K Buy
+543
New +$7.62K ﹤0.01% 1818

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

SageView Advisory Group's RDY Position: Q1 2026 in Review

SageView Advisory Group sold out of Dr. Reddy's Laboratories (RDY) in Q1 2026, closing a stake of 543 shares — an estimated $7.62K sold.

SageView Advisory Group first reported a position in RDY in Q4 2025 and held it in 1 quarter. The position peaked at $7.62K in Q4 2025. 249 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • SageView Advisory Group reported no remaining Dr. Reddy's Laboratories position as of Q1 2026 after selling out during the quarter.
  • SageView Advisory Group sold 543 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $7.62K.
  • SageView Advisory Group first reported a position in Dr. Reddy's Laboratories in Q4 2025 and held it in 1 quarter.
  • SageView Advisory Group's Dr. Reddy's Laboratories position peaked at $7.62K in Q4 2025.
  • 249 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.